Investor profile
Oxford Technology Management has backed 5 European tech companies across 6 funding rounds between 2017 and 2024, joining rounds totalling €16M. Most active in Healthtech and Software. Data as of 7 Aug 2026.
Also recorded as: Oxford Technology
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| DiffBlue | UK | 1 | €5.8M |
| Oxcan | UK | 2 | €4.9M |
| Glide Pharmaceutical Technologies | UK | 1 | €3.7M |
| Sphere Fluidics | UK | 1 | €1.7M |
| MitoRx Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| DiffBlue | Other | €5.8M | 2024-10 |
| Glide Pharmaceutical Technologies | Growth/Late | €3.7M | 2017-02 |
| Oxcan | Other | €3.5M | 2023-01 |
| Sphere Fluidics |
| 1 |
| €0 |
| Other |
| €1.7M |
| 2019-01 |
| Oxcan | Seed | €1.5M | 2021-09 |
